In Vitro Evaluation of Cadmium-Induced Phosphate Reabsorption Impairment

Area of Science:

• Nephrology
• Toxicology
• Cell Biology

Background:

• Cadmium (Cd) accumulates in kidneys, causing phosphate reabsorption issues and hypophosphatemia.
• The precise molecular pathways of Cd-induced phosphate reabsorption dysfunction are not fully understood.

Purpose of the Study:

• To investigate the molecular mechanisms of cadmium's effect on renal phosphate reabsorption using an in vitro model.
• To assess the role of mitochondrial function and dynamics in cadmium nephrotoxicity.

Main Methods:

• Utilized an immortalized rat proximal tubule cell line (NRK-52E) to evaluate cellular phosphate uptake.
• Exposed cells to subtoxic cadmium concentrations and measured phosphate uptake, Npt2a/Npt2c expression, mitochondrial membrane potential, ATP production, and mitochondrial morphology.
• Assessed the impact of OPA1 inhibitors and electron transport chain inhibitors on mitochondrial function and phosphate uptake.

Main Results:

• Subtoxic cadmium concentrations significantly reduced cellular phosphate uptake without affecting Npt2a or Npt2c expression.
• Cadmium exposure led to decreased mitochondrial membrane potential, reduced ATP production, impaired mitochondrial fusion (reduced OPA1), and mitochondrial fragmentation.
• Inhibiting OPA1 or the electron transport chain mimicked cadmium's effects on mitochondrial function and phosphate uptake.

Conclusions:

• Cadmium-induced impairment of renal phosphate reabsorption is linked to OPA1-dependent mitochondrial fusion defects and overall mitochondrial dysfunction.
• This study highlights the critical role of mitochondrial health in maintaining kidney phosphate homeostasis and provides insights into cadmium nephrotoxicity.
• The developed in vitro model shows promise for evaluating reabsorption defects similar to Fanconi syndrome.